ALB and COVID-19: Incidence rates of elevated ALT, Gamma-glutamyl transferase(γ-GT), AST, lactate dehydrogenase (LDH), total bilirubin (TB), and alkaline phosphatase (ALP) were 57.4%, 39.7%, 32.4%, 33.8%, 17.6%, and 7.4%, respectively and the incidence of depleted Alb was 33.8% in the COVID-19 confirmed cases with abnormal liver function (Fig.1).